Key facts
- Aishirui Medical’s last known valuation is $28.9M (May 2025).
- It has raised $12.3M; the latest was Seed Round ($8.3M) in May 2025.
- Notable investors include Addor Capital, Hefei Industry Investment Group, Shenzhen Guozhong Venture Capital Management, Anhui Lianyuan Venture Capital, Hefei Haiheng Innovation Investment — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Aishirui Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Aishirui Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aishirui Medical
Developer of the robot platform designed for surgery. The company's products mainly focus on orthopedic surgery robots and aim to offer complete orthopedic surgery solutions, providing customers with reliable and innovative products.
- Sector
- Information Technology
- HQ
- Hefei, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Aishirui Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aishirui Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aishirui Medical in its N-PORT filings yet. We sweep new filings monthly.